background
prematur
coronari
arteri
diseas
cad
special
entiti
strong
link
famili
hypercholesterolemia
famili
histori
prematur
cad
multipl
coexist
atherosclerot
risk
factor
drugelut
stent
de
includ
paclitaxelelut
stent
pe
sirolimuselut
stent
se
proven
lower
restenot
rate
howev
date
studi
investig
clinic
angiograph
result
de
prematur
cad
patient
method
februari
octob
prematur
cad
patient
defin
younger
year
age
treat
de
medic
center
retrospect
enrol
baselin
clinic
characterist
clinic
outcom
angiograph
followup
result
analyz
result
total
patient
mf
enrol
mean
age
year
rang
year
convent
atherosclerot
risk
factor
preval
studi
group
includ
diabet
mellitu
hypertens
hyperlipidemia
smoke
moreov
homozyg
heterozyg
famili
hypercholesterolemia
case
studi
group
term
angiograph
result
target
lesion
target
vessel
forti
de
pe
se
implant
median
stent
diamet
mm
median
length
mm
clinic
followup
count
may
mean
followup
durat
day
patient
second
angiogram
followup
period
day
de
none
patient
target
lesion
revascular
tlr
addit
differ
tlr
stent
thrombosi
patient
without
acut
coronari
syndrom
conclus
base
singlecent
experi
de
good
shortterm
followup
result
prematur
cad
group
divers
multipl
atherosclerot
risk
factor
j
chin
med
assoc
prematur
coronari
arteri
diseas
cad
patient
special
subgroup
among
atherosclerot
patient
prematur
present
impli
rapidli
progress
diseas
cours
moreov
impact
prematur
myocardi
infarct
mi
cad
young
patient
hisher
famili
particularli
devast
fortun
incid
mi
symptomat
cad
young
adult
low
studi
show
cad
case
occur
age
fact
clinic
manifest
cad
young
adult
rel
uncommon
impli
patient
atyp
gener
popul
cigarett
smoke
shown
singl
factor
strongli
associ
cad
young
adult
kannel
et
al
found
patient
includ
framingham
minghsiung
wang
wenlieng
lee
kuoyang
wang
yucheng
hsieh
tsunjui
liu
ihsiang
lin
weiwen
lin
chihtai
ting
kaewoei
liang
heart
studi
rel
risk
cad
time
higher
smoker
age
compar
nonsmok
age
group
diabet
hyperlipidemia
also
import
associ
risk
factor
prematur
cad
patient
famili
histori
cad
anoth
known
risk
factor
probabl
repres
combin
multipl
risk
factor
drugelut
stent
de
shown
lower
restenot
rate
comparison
baremet
stent
recent
sever
clinic
trial
registri
proven
efficaci
de
highrisk
subset
diabet
small
vessel
long
lesion
howev
studi
investig
efficaci
safeti
de
prematur
cad
patient
usual
associ
multipl
atherosclerot
risk
factor
conduct
retrospect
studi
investig
shortterm
result
de
prematur
cad
patient
divers
multipl
risk
factor
februari
octob
prematur
cad
patient
defin
younger
year
age
treat
de
taichung
veteran
gener
hospit
taichung
taiwan
retrospect
enrol
clinic
characterist
clinic
outcom
angiograph
followup
result
analyz
angiograph
followup
discret
intervent
cardiologist
charg
clinic
followup
retrospect
count
may
acut
coronari
syndrom
ac
includ
st
elev
nonst
elev
mi
cardiac
enzym
elev
unstabl
angina
crescendo
chest
pain
ischem
electrocardiograph
chang
cardiac
enzym
elev
hypertens
defin
systol
blood
pressur
mmhg
diastol
blood
pressur
mmhg
multipl
measur
sit
posit
rest
patient
alreadi
antihypertens
medic
diabet
mellitu
defin
fast
blood
sugar
mgdl
occas
patient
alreadi
oral
hypoglycem
agent
insulin
shot
hyperlipidemia
defin
total
cholesterol
mgdl
lowdens
lipoprotein
cholesterol
ldlc
mgdl
patient
alreadi
hmgcoa
reductas
inhibitor
treatment
famili
histori
prematur
cad
defin
cad
histori
firstdegre
male
rel
age
femal
age
patient
receiv
mg
aspirin
oral
dose
clopidogrel
immedi
procedur
dual
antiplatelet
agent
maintain
least
month
sirolimuselut
stent
se
month
paclitaxelelut
stent
pe
use
either
pe
se
depend
upon
mutual
agreement
patient
intervent
cardiologist
charg
target
vessel
revascular
tvr
consid
driven
ischemia
stenosi
target
vessel
least
lumin
diamet
basi
quantit
analysi
either
electrocardiograph
chang
patient
rest
function
studi
indic
ischemia
distribut
target
vessel
stenosi
least
conjunct
recurr
symptom
alon
target
lesion
revascular
tlr
defin
repeat
revascular
ischemia
owe
stenosi
least
lumin
diamet
anywher
within
stent
within
border
proxim
distal
stent
target
vessel
failur
defin
death
mi
ischemiadriven
tvr
advers
event
could
conclus
attribut
nontarget
vessel
event
consid
target
vessel
failur
complet
angiogram
record
review
angiograph
measur
made
dedic
workstat
softwar
quantit
analysi
angiogram
qca
philip
inturi
suit
classif
coronari
lesion
type
made
base
american
colleg
cardiolog
acc
american
heart
associ
aha
guidelin
binari
restenosi
defin
stenosi
least
diamet
lumin
diamet
previous
treat
lesion
stent
thrombosi
defin
ac
angiograph
document
either
vessel
occlus
thrombu
within
adjac
previous
success
stent
vessel
absenc
angiograph
confirm
either
acut
mi
distribut
treat
vessel
death
cardiac
caus
end
defin
studi
period
continu
variabl
express
mean
standard
deviat
categor
data
percentag
categor
variabl
compar
use
test
without
yate
correct
indic
spss
version
spss
inc
chicago
il
usa
use
calcul
p
valu
less
consid
statist
signific
total
patient
mf
enrol
mean
age
year
median
age
year
rang
year
convent
atherosclerot
risk
factor
preval
studi
group
includ
diabet
mellitu
hypertens
hyperlipidemia
smoke
tabl
mean
number
atherosclerot
risk
factor
particular
homozyg
heterozyg
famili
hypercholesterolemia
patient
studi
homozyg
patient
woman
present
baselin
total
cholesterol
mgdl
tendon
xanthoma
left
main
triplevessel
coronari
diseas
carotid
atherosclerosi
heterozyg
patient
man
baselin
total
cholesterol
mgdl
triplevessel
coronari
diseas
target
lesion
target
vessel
among
lesion
type
c
lesion
refer
vessel
diamet
mm
mean
lesion
length
mm
forti
de
pe
se
implant
median
stent
diamet
mm
median
length
mm
tabl
clinic
followup
count
may
mean
followup
durat
day
drugelut
stent
prematur
cad
eleven
patient
second
angiogram
followup
period
day
de
none
binari
restenosi
tabl
moreov
patient
tlr
clinic
followup
period
howev
patient
interven
vessel
tvr
nontarget
lesion
followup
one
man
patent
pe
site
proxim
obtus
margin
branch
followup
angiogram
restenosi
fardist
obtus
margin
balloon
site
beyond
stent
segment
man
receiv
pe
proxim
left
anterior
descend
arteri
lad
followup
patent
ladproxim
stent
site
previous
untreat
ladmiddl
lesion
becam
signific
intervent
subsequ
perform
balloon
angioplasti
patient
develop
stent
thrombosi
recurr
acut
mi
clinic
followup
period
regard
risk
factor
modif
patient
met
criteria
hypercholesterolemia
total
cholesterol
mgdl
ldlc
mgdl
put
hmgcoa
reductas
inhibitor
treatment
clinic
followup
period
fortytwo
percent
origin
cigarett
smoker
quit
smoke
index
percutan
coronari
intervent
pci
sixteen
studi
patient
admit
due
ac
admit
due
stabl
angina
pectori
differ
tlr
stent
thrombosi
binari
restenosi
ac
nonac
group
two
patient
ac
group
nontarget
lesion
tvr
p
vs
nonac
tabl
prematur
cad
demand
special
clinic
attent
devast
impact
patient
famili
de
gain
popular
among
cardiologist
effect
reduc
restenosi
rate
howev
concern
increas
late
late
stent
thrombosi
rate
de
recent
arisen
though
sever
trial
registri
proven
efficaci
de
gener
popul
studi
focus
de
applic
prematur
cad
group
retrospect
studi
show
de
reliabl
treatment
prematur
cad
group
complex
lesion
divers
multipl
atherosclerot
risk
factor
studi
includ
rare
prematur
cad
case
famili
hypercholesterolemia
one
homozyg
woman
present
baselin
total
cholesterol
mgdl
tendon
xanthoma
left
main
triplevessel
coronari
diseas
carotid
arteri
stenosi
treat
hmgcoa
reductas
inhibitor
plasma
ldl
apheresi
se
implant
left
main
ostium
pe
right
coronari
arteri
howev
skin
biopsi
done
confirm
diagnosi
measur
ldl
receptor
activ
cultur
skin
fibroblast
patient
anoth
limit
followup
coronari
angiogram
case
patient
heterozyg
man
baselin
total
cholesterol
mgdl
ischem
rest
electrocardiogram
strong
posit
treadmil
exercis
test
result
coronari
angiogram
show
triplevessel
coronari
diseas
treat
total
pe
pci
session
radionuclid
exercis
myocardi
perfus
scan
perform
month
later
disclos
neg
ischem
respons
electrocardiographi
scan
indic
good
therapeut
result
studi
base
retrospect
analysi
singl
center
catheter
databank
thu
limit
small
sampl
size
clinic
implic
studi
also
limit
de
brand
select
pe
well
gender
bia
male
anoth
limit
studi
patient
second
coronari
angiogram
followup
period
moreov
studi
patient
present
acut
mi
accord
literatur
youngag
acut
mi
associ
thrombu
less
plaqu
thu
inher
lower
restenot
rate
anoth
shortcom
studi
lack
olderag
control
group
receiv
de
treatment
studi
time
frame
mean
number
atherosclerot
risk
factor
studi
treat
lesion
accaha
class
c
though
treat
lesion
complex
clinic
scenario
high
risk
restenosi
shortterm
followup
result
disclos
target
vessel
failur
result
compat
publish
clinic
trial
highrisk
subset
studi
result
indic
young
age
prematur
cad
limit
desbas
pci
current
practic
moreov
recent
result
courag
trial
boden
et
al
emphas
import
risk
factor
modif
treatment
stabl
angina
pectori
studi
result
young
prematur
cad
subject
prove
notion
patient
hypercholesterolemia
put
hmgcoa
reductas
inhibitor
treatment
clinic
followup
period
conclus
base
singlecent
experi
de
reliabl
treatment
low
tlr
prematur
cad
group
complex
lesion
divers
multipl
atherosclerot
risk
factor
